Bibliografía del artículo
1. Schuijer M, Berns EM. TP53 and ovarian cancer. Hum Mutat 2003, 21:285-291.
2. Gojnic M, Pervulov M, Petkovic S, Papic M. Diagnosis of borderline ovarian cancers in pregnancy. Clin Exp Obstet Gynecol 2004, 31:45-6.
3. Leake JF. Long term follow-up of serous ovarian tumors of low malignant potencial. Gynecol Oncol 1992, 47:150-158.
4. Morice P, Camatte S, Rey A, Atallah D, Lhomme C, Pautier P y col. Prognostic factors for patients with advanced stage serous borderline tumours of the ovary. Ann Oncol 2003, 14:592-598.
5. Morice P, Camatte S, Rouzier R, Pautier P, Atallah D, Pomel C y col. Prognostic factors and treatment for advanced-stage borderline ovarian tumors. J Gynecol Obstet Biol Reprod 2002, 31:623-638.
6. Young RC, Walton LA, Ellenberg SS, Momesley H, Wilbanks GD, Decker DG y col. Adjuvant therapy in stage I and stage II epithelial ovarian cancer. N Engl J Med 1990, 322:1021-1027.
7. Snider DD. Evaluation of surgical staging in stage I low malignant potencial ovarian tumors. Gynecol Oncol 1991, 40:129-132.
8. Koern J, Trope CG, Abeler VM. A retrospectic study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982. Cancer 1993, 71:1810-1820.
9. Morice P, Camatte S, Wickart-Poque F, Rozier P, Pautier P, Pomel C y col. Conservative management of malignant and borderline ovarian tumor. Bull Cancer 2003, 89:1019-1026.
10. Leitao MM, Boyd J, Hummer A, Olvera N, Arroyo CD,Venkatraman E y col. Clinicopathologic análisis of early stage sporadic ovarian carcinoma. Am J Surg Pathol 2004, 28:147-159.
11. Sherman ME, Mink PJ, Curtis R, Cote TR, Brooks S, Hartge P y col. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population based analysis. Cancer 2004, 100:1045-1052.
12. Behtash N, Modares M, Abolhasani M, Ghaemmaghami F, Mousavi M, Yarandi F y col. Borderline ovarian tumours: clinical analysis of 38 cases. J Obstet Gynaecol 2004, 24:157-160.
13. Chan JK, Lin YG, Loizzi V, Ghobriel M, Disaia PJ, Berman ML. Borderline ovarian tumours in reproductive age women. Fertility sparing surgery and outcome. J Reprod Med 2003, 48:756-760.
14. Pilli GS, Suneeta KP, Dhaded AV, Yenni VV. Ovarian tumours: a study of 282 cases. J Indian Med Assoc 2002, 100:423-4,447.
15. Makarewicz H, Emerich J, Olszewski J. Comparison of two groups of patients with serous and mucinous types of borderline ovarian tumors. Ginekol Pol 2003, 74:24-31.
16. Seidman JD, Kurman RJ. Pathology of ovarian carcinoma. Hematol Oncol Clin North Am 2003, 17:909-925.
17. Idotta R, Scopelliti P, Polimeni C, Lirosi MF. Serous papillary cystic ovarian borderline tumor : a case report. Clin Exp Obstet Gynecol 2002, 29:293-296.
18. Piura B, Dgani R, Blickstein I, Yanai-Inbar I, Czernobilsky B, Glezerman M. Epithelial ovarian tumors of borderline malignancy: a study of 50 cases. Int J Gynecol Cancer 1992, 2:189-197.
19. Makarewicz H, Emerich J, Olszewski J, Klasa-Mazurkiewicz D. Conservative treatment of patients with borderline ovarian tumors. Ginekol Pol 2001, 72:134-138.
20. Makar AP, Kaern J, Kristensen GB, Vergote I, Bormer OP, Trope CG. Evaluation of serum CA125 level asa tumor marker in borderline tumors ofthe ovary. Int J Gynecol Cancer 1993, 3:299-303.
21. Makarewicz-Olszewska H, Emerich J, Kobierski J. Evolution of surgical treatments in patients with borderline ovarian tumors. Ginekol Pol 2002, 73:1021-1026.
22. Camatte S, Morice P, Atallah D, Pautier P, Lhomme C, Haie-Meder C y col. Lymph node disorders and prognostic value of nodal involvement in patients treated for a borderline ovarian tumor: an analysis of a series of 42 lymphadenectomies. J Am Coll Surg 2002, 195:332-338.
23. Querlei D, Papageorgiou T, Lambaudie E, Sonoda Y, Narducci F, Leblanc E. Laparoscopic restaging of borderline ovarian tumors: results of 30 cases initally presumed as stage IA borderline ovarian tumors. BJOG 2003,110:201-204.
24. Camatte S, Morice P, Atallah D, Thoury A, Pautier P, Lhomme C y col. Clinical outcome after laparoscopic pure management of borderline ovarian tumors: results of a series of 34 patients. Ann Oncol 2004, 15:605-609.
25. Hogberg T, Glimelius B, Nygren P, SBU-Group. A systematic overview of chemoterapy effects in ovarian cancer. Acta Oncol 2001, 40:340-360.